Plain-English translation of NCT06616194 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Migraine research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a medication called to see if it can help prevent migraines in teenagers who have frequent headaches. is a tablet that dissolves under your tongue and may help reduce how often migraines happen. The study will compare how this medication works compared to a placebo (a pill with no medicine in it) to find out if it's safe and effective.
Many teenagers suffer from chronic migraines that significantly impact their daily lives, school, and activities. This trial exists to find out whether this medication could offer a new, effective way to prevent these frequent attacks and improve quality of life for young people.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic about every 4 weeks for up to 19 visits over 15 months total. In the first 3 months, you'd take either the new medication or a placebo every other day—neither you nor the doctors would know which one you're taking. After that, everyone continues with the medication for a full year to see how safe it is long-term. At each visit, you'll have a health check and blood test, and you'll keep a daily diary tracking your migraines. Some visits may happen at home instead.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States